Aptamer Inhibits Tumor Growth by Leveraging Cellular Proteasomal Degradation System to Degrade c‐Met in Mice
Kun Chen(Eye & ENT Hospital of Fudan University), Weihong Tan(Petronas (Malaysia)), Zilong Zhao(The University of Texas MD Anderson Cancer Center), Jiamin Cai(Hunan University), Xiaobing Zhang(Hunan University), Yingying Li(Shenzhen Institutes of Advanced Technology), Ting Fu(Salk Institute for Biological Studies), Chan Yang(Hunan University), Sujuan Wang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 1
Related Papers
Conjugation of Biomolecules with Luminophore-Doped Silica Nanoparticles for Photostable Biomarkers
|Analytical Chemistry|2001|748
Nanotechnology in Therapeutics: A Focus on Nanoparticles as A Drug Delivery System
|Nanomedicine|2012|609
Preparation and antibacterial activity of Fe<sub>3</sub>O<sub>4</sub>@Ag nanoparticles
|Nanotechnology|2007|600
Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation
|Nature Communications|2016|597
Activatable Fluorescence/MRI Bimodal Platform for Tumor Cell Imaging via MnO<sub>2</sub> Nanosheet–Aptamer Nanoprobe
|Journal of the American Chemical Society|2014|585